SIM
CRL icon

Sentry Investment Management’s Charles River Laboratories CRL Stock Holding History

Sentry Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-135
Closed -$27K – 114
2025
Q4 		$27K Hold
135
– – 0.02% 483
2025
Q3 		$23K Buy
+135
New +$21.4K 0.02% 508
2025
Q2 		– Sell
-146
Closed -$20K – 499
2025
Q1 		$20K Sell
146
-44
-23% -$7.38K 0.01% 474
2024
Q4 		$35K Sell
190
-31
-14% -$5.97K 0.02% 434
2024
Q3 		$44K Hold
221
– – 0.02% 449
2024
Q2 		$46K Sell
221
-45
-17% -$10.2K 0.02% 422
2024
Q1 		$72K Hold
266
– – 0.03% 397
2023
Q4 		$63K Sell
266
-29
-10% -$5.7K 0.03% 415
2023
Q3 		$58K Sell
295
-32
-10% -$6.57K 0.03% 445
2023
Q2 		$69K Hold
327
– – 0.03% 455
2023
Q1 		$66K Hold
327
– – 0.03% 431
2022
Q4 		$71K Hold
327
– – 0.03% 420
2022
Q3 		$64K Hold
327
– – 0.03% 435
2022
Q2 		$70K Sell
327
-64
-16% -$15.6K 0.03% 442
2022
Q1 		$111K Sell
391
-138
-26% -$42.6K 0.04% 420
2021
Q4 		$199K Buy
529
+97
+22% +$37.7K 0.05% 322
2021
Q3 		$178K Sell
432
-34
-7% -$14.1K 0.05% 339
2021
Q2 		$172K Buy
+466
New +$156K 0.04% 358

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sentry Investment Management's CRL Position: Q1 2026 in Review

Sentry Investment Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 135 shares — an estimated $27K sold.

Sentry Investment Management first reported a position in CRL in Q2 2021 and held it in 18 quarters. The position peaked at $199K in Q4 2021. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Sentry Investment Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 135 Charles River Laboratories shares in Q1 2026, an estimated $27K.
  • Sentry Investment Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 18 quarters.
  • Sentry Investment Management's Charles River Laboratories position peaked at $199K in Q4 2021.
  • 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.